Newmont Corporation vs Roivant Sciences Ltd. Common Shares — how do they compare? Newmont Corporation trades at $118.51 (market cap $121.75B), while Roivant Sciences Ltd. Common Shares trades at $35.12 (market cap $24.72B). The key difference: Newmont Corporation is far larger — about 4.9× Roivant Sciences Ltd. Common Shares's market cap, and Newmont Corporation pays a 0.9% dividend while Roivant Sciences Ltd. Common Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Newmont Corporation for 58 Days and Roivant Sciences Ltd. Common Shares for 1 Days on average.
| NEM | ROIV | |
|---|---|---|
Market Cap | $121.75B | $24.72B |
Volume | 5,421,125 | 6,279,442 |
Sector | Basic Materials | Health |
52-Week High | $135.14 | $41.81 |
52-Week Low | $78.63 | $16.04 |
Typical Hold Time | 58 Days | 1 Days |
Enterprise Value | $118.34B | $20.99B |
Dividend Yield | 0.9% | — |
Signals from Pluang's Aura AI — not financial advice
Newmont (NEM) trades at $118.23, up 4.13% today, supported by strong earnings beats and record free cash flow. The stock shows a bearish technical signal near key support at $114, while fundamentals are robust with a P/E of 14.57, net income margin of 33.36%, and revenue growth to $22.67B in 2025. Analyst consensus is strongly bullish with a $136.83 price target.
The outlook for NEM is positive, driven by operational improvements and a constructive gold market. Key risks include gold price volatility and execution of growth projects. With no analyst sell ratings and strong institutional interest, the stock presents a compelling opportunity for investors seeking exposure to a leading gold producer.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Newmont Corp is primarily a gold producer with operations and/or assets in the United States, Canada, Mexico, Dominican Republic, Peru, Suriname, Argentina, Chile, Australia, and Ghana. It is also engaged in the production of copper, silver, lead and zinc. The company's operations are organized in five geographic regions: North America, South America, Australia, Africa and Nevada.
Read more on NEM →Roivant Sciences develops medicines by building and supporting biotechnology subsidiaries, known as Vants. Its programs span areas such as immunology, neuroscience, and rare diseases.
Read more on ROIV →